KCT0003134已完成未知
Post marketing surveillance on safety and efficacy of Diquas eye drops 3% in Korean patients in accordance with 'Regulation for re-examination of new drugs, etc.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •Patients with dry eye syndrome
排除标准
- 未提供
研究者
相似试验
已完成
4 期
This is an observational study to determine the efficacy and safety of vitamin-c in facial photodamageCTRI/2010/091/001161Cipla Ltd24
已完成
4 期
A post marketing study to collect safety data of Gardasil when administered in routine practice to females between 9 to 45 years of ageCTRI/2015/09/006183MSD Pharmaceuticals PvtLtd
招募中
4 期
Post Marketing surveillance study to evaluate the safey of liposomal Amphotericine B (Gufisome)inpatient of Invasive fungal infectioCTRI/2022/08/044680Gufic Biosciences Limited
已完成
不适用
Post-market surveillance study to prove the safety and performance of Vanguard PS RPKnee joint deseasesJPRN-UMIN000023965Zimmer Biomet G.K.100
已完成
4 期
A post-marketing study of the marketed product Maxtra® P syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031189Zuventus Healthcare Limited200